Nathan Cox represents public and private companies in a range of corporate and securities matters, including public offerings, private financings, SEC reporting and compliance, corporate governance and mergers and acquisitions.

Download full bio 


  • Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion 

  • Dynavax Technologies – $200 Million Convertible Notes Offering 

  • Treace Medical Concepts – $220 Million IPO 

  • Talis Biomedical – $254 Million IPO 

  • Horizon Therapeutics to Acquire Viela Bio 

  • View all


  • UCLA School of Law
    JD, 2019

  • Nova Southeastern University
    BA, Philosophy
    with distinction, 2013

Admissions & Credentials


Not admitted to practice in Washington